BI
Biogen Inc
🇺🇸XNAS.BIIBUnited StatesHealthcare
$217.09USDup +0.89 (+0.41%)OpenDelayed6:08 PM
Price$217.09+0.89 (+0.41%)
Profile
- Healthcare
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US09062X1037
- CUSIP
- 449370105
Company
- Employees
- 7,500
- Headquarters
- Cambridge, United States
- Website
- https://www.biogen.com
- CEO
- Mr. Christopher A. Viehbacher
Market
- Shares outstanding
- 147.8M
- Market cap
- $32.08B
Key dates
- Next earnings
- Oct 29, 2026
Highlights
- Market cap
- $31.73B
- EPS LTM
- $5.65calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 38.41calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $9.95B-0.49%down year on year
- Net income
- $835.09M-45.44%down year on year
- Gross margin
- 67.71%-6.65%down year on year
- Free cash flow
- $2.97B+59.89%up year on year
Other listings
- XSTU.IDPStuttgart Stock Exchange
- XETR.IDPXetra
- XFRA.IDPFrankfurt Stock Exchange
- XMEX.BIIBMexican Stock Exchange
- BVMF.BIIB34B3 - Brasil Bolsa Balcão
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.